A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Viatris Inc stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 10,000 shares of VTRS stock, worth $130,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,001 0.01%
Holding current value
$130,000
Previous $106,000 9.43%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.32 - $12.13 $10 - $12
-1 Reduced 0.01%
10,000 $116,000
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $845,250 - $1.01 Million
-75,000 Reduced 88.23%
10,001 $119,000
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $8 - $10
1 Added 0.0%
85,001 $920,000
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $719,250 - $851,250
75,000 Added 750.0%
85,000 $838,000
Q2 2023

May 17, 2024

SELL
$9.02 - $10.29 $9 - $10
-1 Reduced 0.01%
10,000 $99,000
Q1 2023

May 17, 2024

BUY
$9.2 - $12.26 $51,519 - $68,656
5,600 Added 127.27%
10,000 $96,000
Q1 2023

May 15, 2023

BUY
$9.2 - $12.26 $51,519 - $68,656
5,600 Added 127.27%
10,000 $96,000
Q4 2022

May 17, 2024

SELL
$8.72 - $11.56 $48,840 - $64,747
-5,601 Reduced 56.0%
4,400 $48,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $7,385 - $9,791
-847 Reduced 16.14%
4,400 $48,000
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $1,789 - $2,172
-148 Reduced 2.74%
5,247 $71,000
Q2 2021

Aug 16, 2021

SELL
$12.97 - $16.15 $191,865 - $238,906
-14,793 Reduced 73.28%
5,395 $77,000
Q1 2021

May 17, 2021

SELL
$13.59 - $18.54 $300,026 - $409,307
-22,077 Reduced 52.23%
20,188 $283,000
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $604,389 - $792,046
42,265 New
42,265 $766,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Portfolio

Follow Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.